Forecasting drug utilization and expenditure in a metropolitan health region

Health Spending Projections Through 2019: The Recession’s Impact Continues

(2010) Christopher J. Truffer et al.   HEALTH AFFAIRS

Projecting future drug expenditures—2009

(2009) James M. Hoffman et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Orphan drug development is not taking off

(2009) Roberta Joppi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Human papillomavirus vaccine: recommendations, issues and controversies

(2009) Randall Fisher et al.   CURRENT OPINION IN PEDIATRICS

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

Being NICE is not the problem!

(2009) Bengt Jonsson   EUROPEAN JOURNAL OF CANCER

Ten years of rituximab in NHL

(2009) Matthew C Winter et al.   Expert Opinion On Drug Safety

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment

(2009) Björn Wettermark et al.   HEALTH POLICY

European Commission takes on Big Pharma

(2009) André den Exter   LANCET

2008 FDA drug approvals

(2009) Bethan Hughes   NATURE REVIEWS DRUG DISCOVERY

Dronedarone for Atrial Fibrillation — An Odyssey

(2009) Peter J. Zimetbaum   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

(2009) Stefan H. Hohnloser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine

(2009) J. S. Ross et al.   ONCOLOGIST

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

(2009) Brian Godman et al.   Expert Review of Pharmacoeconomics & Outcomes Research

New drugs in multiple myeloma

(2009) James R Berenson et al.   Current Opinion in Supportive and Palliative Care

HIV epidemiology and the effects of antiviral therapy on long-term consequences

(2008) Thomas C Quinn   AIDS

Review article: current management of metastatic colorectal cancer - the evolving impact of targeted drug therapies

(2008) T. YAU et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Projecting future drug expenditures--2008

(2008) J. M. Hoffman et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

New Drugs for Chronic Hepatitis B: A Review

(2008) Emilio Palumbo   AMERICAN JOURNAL OF THERAPEUTICS

Targeted Drugs in Chronic Myeloid Leukemia

(2008) Joanna Gora-Tybor et al.   CURRENT MEDICINAL CHEMISTRY

Enhancing the rational use of new medicines across European health care systems

(2008) Silvio Garattini et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Clinical and Preclinical Rationale for CGRP-Receptor Antagonists in the Treatment of Migraine

(2008) Stewart J. Tepper et al.   HEADACHE

National Health Spending In 2006: A Year Of Change For Prescription Drugs

(2008) Aaron Catlin et al.   HEALTH AFFAIRS

Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003

(2008) Frank R. Lichtenberg   HEALTH ECONOMICS

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials

(2008)   LANCET

Tier 4 Drugs and the Fraying of the Social Compact

(2008) Thomas H. Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

Current and future management of chronic hepatitis C infection

(2008) T J S Cross et al.   POSTGRADUATE MEDICAL JOURNAL

Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries

(2007) Livio Garattini et al.   HEALTH POLICY